1[1]Lang PF,Makinen JI,Irjala KMA,Rantal MI,et al.Glucose instillation vs.expectant management of tubal pregnancy with serum HCG＜2500 mIU/ml.Acta Obstet Gynecol Scand,1997,76:797.
2[2]Rantala,Makinen.Tubal patency and fertility outcome after expectant management of ectopic pregnancy.Fertil Steril,1997,68 (6):1043.
3[3]Ance BN.Medical management of ectopic pregnancy.Clin Obstet Gynecol,1998,41:382.
4[4]Thomas GS.Medical management should be routinely used as primary therapy for ectopic pregnancy.Clin Obstet Gynecol,1995,38:346.
5Vassilidon N, Balmer J. Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: evidance that endometrial granulated lymphocytes are absent from the tubal implantation site.Fertil Steril, 1998,69 (4) :760.
6Creinin MD, Drohn MA. Metrotrexate pharmacokinetics and effects in women receiving metrotrexate 50mg and 60mg per square meter for early abortion. Am J Obstet Gynecol,1997,177(6) :1444.
7Isaacs JD, Mcgehee RP, Cowan BD. Life threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol, 1996,88 (4Pt2) :694.
8Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gyncol,1997,176(3) :714.
9Ben-Shlomo I, Eliyahu S, Yanai N, et al. Methotrexate as a possible cause of ovarian cysts formation: experience with women treated for ectopic pregnancies. Fertil Steri], 1997,67 (4) :786.
10Perdu M, Camus E, Rozenberg P, et al. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase Ⅱ non - randomized study. Am J Obstet Gynecol, 1998,179 ( 3 Pt 1 ) :640.
